Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Symyx Technologies buys Integrity Biosolution
September 2008
SHARING OPTIONS:

SANTA CLARA, Calif.Symyx Technologies Inc. announced last month it acquired Camarillo, Calif.-based Integrity Biosolution LLC in an all-cash transaction. IntegrityBio is a contract formulation research and analytical services company, providing formulation and stability solutions for large molecule biopharmaceuticals along with Good Manufacturing Practices (GMP) fill/finish services for Phase I and II clinical trial volumes. Specific terms of the acquisition were not disclosed.

The acquisition expands Symyx's Research Service offerings in life sciences into biologic formulations, complementing its existing chemical formulations services. The combination of Symyx and IntegrityBio creates a differentiated set of large molecule formulation services to customers in the pharmaceutical and biotechnology industries by combining IntegrityBio's formulation expertise with Symyx's advanced high-throughput research and informatics capabilities.

"The acquisition of IntegrityBio is another milestone in the growth of Symyx Research Services and it enables Symyx to offer customers a highly competitive formulation service in biologics," says Isy Goldwasser, CEO of Symyx. "We can leverage our expertise in informatics and automated parallel experimentation to improve the consistency, accuracy, data capture capabilities and quality of reporting within this market.  This is an important change in formulation outsourcing." DDN

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.